Michael Lichtenauer1, Bernhard Wernly1, Vera Paar1, Ilonka Rohm2, Christian Jung3, Atilla Yilmaz4, Uta C Hoppe1, Paul Christian Schulze2, Daniel Kretzschmar2, Rudin Pistulli2. 1. Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria. 2. Division of Cardiology, Angiology, Pneumology and Intensive Medical Care, Department of Internal Medicine I, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany. 3. Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Duesseldorf, Duesseldorf, Germany. 4. Clinic of Internal Medicine II, Elisabeth Klinikum Schmalkalden, Schmalkalden, Germany.
Abstract
INTRODUCTION: Fetuin-A has been described to correlate inversely with vascular calcification both in animal models but also in patients with heart and renal disease. In this current study, we sought to investigate whether fetuin-A might be a useful marker for the discrimination of ischemic (ICM) from dilated cardiomyopathy (DCM). METHODS: A total of 124 non-consecutive patients were included in this study, 59 patients suffered from ICM and 65 patients from DCM. Serum samples were obtained during out-patient visits and analyzed for fetuin-A by ELISA. RESULTS: Median fetuin-A concentration in the overall cohort was significantly lower in ICM patients compared to DCM patients (62.2±16.4 μg/mL vs. 129.6±56.6 μg/mL; P<.001). A positive correlation of fetuin-A levels was found with BMI, cholesterol, LDL/HDL ratio and triglycerides and an inverse correlation with age (r=-.36; P<.001). Moreover, patients suffering from (stable) angina pectoris evidenced lower fetuin-A levels compared to non-symptomatic patients (73.1±22.7 μg/mL vs. 83.7±26.2 μg/mL; P=.047) CONCLUSIONS: Fetuin-A was shown to be a potential discriminator and biomarker for the differential diagnosis between ICM and DCM. Fetuin-A levels might also be helpful in the process of diagnostic decision-making in regards to invasive management or medical therapy.
INTRODUCTION:Fetuin-A has been described to correlate inversely with vascular calcification both in animal models but also in patients with heart and renal disease. In this current study, we sought to investigate whether fetuin-A might be a useful marker for the discrimination of ischemic (ICM) from dilated cardiomyopathy (DCM). METHODS: A total of 124 non-consecutive patients were included in this study, 59 patients suffered from ICM and 65 patients from DCM. Serum samples were obtained during out-patient visits and analyzed for fetuin-A by ELISA. RESULTS: Median fetuin-A concentration in the overall cohort was significantly lower in ICM patients compared to DCMpatients (62.2±16.4 μg/mL vs. 129.6±56.6 μg/mL; P<.001). A positive correlation of fetuin-A levels was found with BMI, cholesterol, LDL/HDL ratio and triglycerides and an inverse correlation with age (r=-.36; P<.001). Moreover, patients suffering from (stable) angina pectoris evidenced lower fetuin-A levels compared to non-symptomatic patients (73.1±22.7 μg/mL vs. 83.7±26.2 μg/mL; P=.047) CONCLUSIONS:Fetuin-A was shown to be a potential discriminator and biomarker for the differential diagnosis between ICM and DCM. Fetuin-A levels might also be helpful in the process of diagnostic decision-making in regards to invasive management or medical therapy.
Authors: Marcel Roos; Maximilian von Eynatten; Uwe Heemann; Dietrich Rothenbacher; Hermann Brenner; Lutz P Breitling Journal: Am J Cardiol Date: 2010-04-27 Impact factor: 2.778
Authors: Christian Jung; Buntaro Fujita; Alexander Lauten; Michael Kiehntopf; Friedhelm Küthe; Markus Ferrari; Hans-Reiner Figulla Journal: Int J Cardiol Date: 2011-09-10 Impact factor: 4.164
Authors: Gysèle S Bleumink; Anneke M Knetsch; Miriam C J M Sturkenboom; Sabine M J M Straus; Albert Hofman; Jaap W Deckers; Jacqueline C M Witteman; Bruno H Ch Stricker Journal: Eur Heart J Date: 2004-09 Impact factor: 29.983
Authors: Ralf Koos; Vincent Brandenburg; Andreas Horst Mahnken; Georg Mühlenbruch; Sven Stanzel; Rolf W Günther; Jürgen Floege; Willy Jahnen-Dechent; Malte Kelm; Harald Peter Kühl Journal: Eur Heart J Date: 2009-05-08 Impact factor: 29.983
Authors: Qi Sun; Monik C Jiménez; Mary K Townsend; Eric B Rimm; JoAnn E Manson; Christine M Albert; Kathryn M Rexrode Journal: J Am Heart Assoc Date: 2014-06-24 Impact factor: 5.501
Authors: Michael Lichtenauer; Bernhard Wernly; Vera Paar; Ilonka Rohm; Christian Jung; Atilla Yilmaz; Uta C Hoppe; Paul Christian Schulze; Daniel Kretzschmar; Rudin Pistulli Journal: J Clin Lab Anal Date: 2017-02-18 Impact factor: 2.352